TransMedics Group Inc (NAS:TMDX)
$ 59.82 -1.2 (-1.97%) Market Cap: 2.01 Bil Enterprise Value: 2.24 Bil PE Ratio: 63.64 PB Ratio: 9.56 GF Score: 70/100

Transmedics Group Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2023 / 01:15AM GMT
Release Date Price: $59.62 (+3.15%)
K. Gong
JPMorgan Chase & Co, Research Division - Associate

Okay. Hello, everyone. Welcome to the last session of Wednesday here at the JPMorgan Healthcare Conference. My name is Allen Gong. I'm on the medical supplies and devices team here at JPMorgan. It's my pleasure to introduce Waleed Hassanein and some of the other management team from TransMedics. We're going to start with some prepared remarks and then move into Q&A.

Waleed H. Hassanein
TransMedics Group, Inc. - Founder, President, MD, CEO & Director

Thanks, Allen, and thanks to JPMorgan for the kind invite, and thank you all for being here. I guess the med tech team left the best for last. So I promise to be light and don't spend too much time to delay your cocktail hour after this, so.

I'm Waleed Hassanein. I'm the Founder, President and CEO of TransMedics and I have the privilege to be accompanied here today by Stephen Gordon, my CFO; and Dr. Tamer Khayal, our Chief Commercial Officer who will be happy to address any of your questions after the presentation.

Just a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot